BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6130620)

  • 1. [Withdrawal of preparations blocking beta-adrenergic receptors].
    Prichard BN; Bhattacharjee P; Tomlinson B; Walden RJ
    Ter Arkh; 1982; 54(11):38-45. PubMed ID: 6130620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Beta-blocker withdrawal syndrome].
    Goliakov VN; Zimin IuV
    Klin Med (Mosk); 1984 Mar; 62(3):15-22. PubMed ID: 6143853
    [No Abstract]   [Full Text] [Related]  

  • 3. [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].
    Plouin PF
    Therapie; 1984; 39(4):379-90. PubMed ID: 6148791
    [No Abstract]   [Full Text] [Related]  

  • 4. The beta-adrenergic blockade withdrawal phenomenon.
    Walden RJ; Tomlinson B; Bhattacharjee P; Prichard BN
    J Pharmacol; 1983; 14 Suppl 2():35-48. PubMed ID: 6138470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beta-adrenergic blockade withdrawal phenomenon.
    Prichard BN; Tomlinson B; Walden RJ; Bhattacharjee P
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S56-62. PubMed ID: 6188921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.
    Prichard BN; Walden RJ
    Br J Clin Pharmacol; 1982; 13(Suppl 2):337S-343S. PubMed ID: 6125186
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial sensitivity to isoproterenol following abrupt propranolol withdrawal in conscious dogs.
    Webb JG; Newman WH; Walle T; Daniell HB
    J Cardiovasc Pharmacol; 1981; 3(3):622-35. PubMed ID: 6168842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Withdrawal of beta-blocking agents in patients with coronary artery disease (author's transl)].
    Meier M; Burckhardt D
    Schweiz Rundsch Med Prax; 1979 Jun; 68(23):721-2. PubMed ID: 36607
    [No Abstract]   [Full Text] [Related]  

  • 9. Abrupt withdrawal of cardiovascular drugs.
    Gerber JG; Nies AS
    N Engl J Med; 1979 Nov; 301(22):1234-5. PubMed ID: 228192
    [No Abstract]   [Full Text] [Related]  

  • 10. Heart rate after combined vagal and sympathetic blockade with atropine and different beta-receptor blocking agents.
    Fenyvesi T; Káldor A; Sebestyén K
    Int J Clin Pharmacol; 1973 Nov; 8(3):254-7. PubMed ID: 4149237
    [No Abstract]   [Full Text] [Related]  

  • 11. [Withdrawal symptoms after discontinuation of beta-adrenolytic drugs].
    Markiewicz A; Karel M
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1452-5. PubMed ID: 2421274
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beta-blockaders and angina pectoris].
    Broustet JP; Emeriau JP; Conri C; Vallaud F; Clementy J
    Coeur Med Interne; 1978; 17(1):95-109. PubMed ID: 25162
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the effects of isoproterenol administered into the hippocampus, frontal cortex, or amygdala on behavior of rats maintained by differential reinforcement of low response rate.
    Zhang HT; Frith SA; Wilkins J; O'Donnell JM
    Psychopharmacology (Berl); 2001 Dec; 159(1):89-97. PubMed ID: 11797075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal.
    Kähkönen S; Bondarenko B; Lipsanen J; Zvartau E
    Int J Psychophysiol; 2007 Dec; 66(3):225-30. PubMed ID: 17761330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intrinsic sympathomimetic activity on beta-receptor responsiveness after beta-adrenoceptor blockade withdrawal.
    Walden RJ; Bhattacharjee P; Tomlinson B; Cashin J; Graham BR; Prichard BN
    Br J Clin Pharmacol; 1982; 13(Suppl 2):359S-364S. PubMed ID: 6125188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Problems caused by withdrawal of beta blockers].
    Gadeholt G
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1543-4. PubMed ID: 1971125
    [No Abstract]   [Full Text] [Related]  

  • 18. Basic autonomic nervous function in patients with neurocardiogenic syncope.
    Saito F; Imai S; Tanaka N; Tanaka H; Suzuki K; Takase H; Aoyama H; Matsudaira K; Ebuchi T; Akamine Y; Takahashi N; Sugino K; Kanmatsuse K; Yagi H; Kushiro T
    Clin Exp Hypertens; 2007 Apr; 29(3):165-73. PubMed ID: 17497343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta-adrenergic blockers].
    Belovezhdov N
    Vutr Boles; 1986; 25(4):14-22. PubMed ID: 2876553
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical studies and experiences with beta-adrenergic blocking agents in the treatment of sinus tachycardia in children].
    Diekmann L
    Arztl Forsch; 1970 Jan; 24(1):13-8. PubMed ID: 4398686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.